Transplantation, AutologousStem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsMelphalanMultiple MyelomaCombined Modality TherapyPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsRemission InductionSalvage TherapyTransplantation ConditioningEtoposideTreatment OutcomeThiotepaHematopoietic Stem Cell MobilizationHodgkin DiseaseDisease-Free SurvivalLymphoma, Non-HodgkinCarmustineBone Marrow PurgingCytarabineCyclophosphamideVincristineEmbryonic Stem CellsAdult Stem CellsAmyloidosisRecurrenceMyeloablative AgonistsLymphoma, Mantle-CellSurvival RateBoronic AcidsPyrazinesDexamethasonePluripotent Stem CellsThalidomideLymphoma, T-Cell, PeripheralLymphoma, FollicularDoxorubicinAntigens, CD34Survival AnalysisMesenchymal Stem Cell TransplantationAntibodies, Monoclonal, Murine-DerivedBone Marrow TransplantationIfosfamideAutograftsCell DifferentiationStem Cell NicheMesenchymal Stromal CellsWhole-Body IrradiationInduced Pluripotent Stem CellsRetrospective StudiesAntineoplastic Agents, AlkylatingTransplantation, HomologousNeural Stem CellsPrognosisLeukapheresisPodophyllotoxinGranulocyte Colony-Stimulating FactorInduction ChemotherapyPrednisoneFollow-Up StudiesBusulfanLymphoma, Large B-Cell, DiffuseLymphomaMultipotent Stem CellsTime FactorsBlood Transfusion, AutologousMaintenance ChemotherapyLymphoma, B-CellStem Cell FactorCells, CulturedMitoxantroneAntineoplastic AgentsEnteropathy-Associated T-Cell LymphomaBone Marrow CellsGraft SurvivalNeoplasm, ResidualInfusions, SpinalBlood Component RemovalLeukemia, Plasma CellCarboplatinHematologic NeoplasmsIdarubicinCell LineageRadioimmunotherapyImmunoglobulin Light ChainsNeoplasms, Second PrimaryBone MarrowHematopoiesisFeasibility StudiesKeratins, Type IIStem Cell ResearchAntibodies, MonoclonalLife TablesFlow CytometryMedulloblastomaMucositisPlant Stems